Quantification of dimethylamine in low concentration particulate matter by reducing the concentration of 9-fluorenylmethyl chloroformate.

Autor: García-Alonso S; Technology Department, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Madrid 28040, Spain. susana.garcia@ciemat.es., Gómez-Moreno FJ; Environment Department, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Madrid 28040, Spain., Alonso-Blanco E; Environment Department, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Madrid 28040, Spain., Pérez-Pastor RM; Technology Department, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Madrid 28040, Spain. susana.garcia@ciemat.es.

Publikováno v: Analytical methods : advancing methods and applications [Anal Methods] 2024 Dec 19; Vol. 17 (1), pp. 145-154. Date of Electronic Publication: 2024 Dec 19.

Characterization of Partial Discharges in Dielectric Oils Using High-Resolution CMOS Image Sensor and Convolutional Neural Networks.

Autor: Monzón-Verona JM; Electrical Engineering Department (DIE), University of Las Palmas de Gran Canaria, 35017 Las Palmas de Gran Canaria, Spain.; Institute for Applied Microelectronics, University of Las Palmas de Gran Canaria, 35017 Las Palmas de Gran Canaria, Spain., González-Domínguez P; Electrical Engineering Department (DIE), University of Las Palmas de Gran Canaria, 35017 Las Palmas de Gran Canaria, Spain.; Institute for Applied Microelectronics, University of Las Palmas de Gran Canaria, 35017 Las Palmas de Gran Canaria, Spain., García-Alonso S; Department of Electronic Engineering and Automatics (DIEA), University of Las Palmas de Gran Canaria, 35017 Las Palmas de Gran Canaria, Spain.

Publikováno v: Sensors (Basel, Switzerland) [Sensors (Basel)] 2024 Feb 18; Vol. 24 (4). Date of Electronic Publication: 2024 Feb 18.

The WNK1-ERK5 route plays a pathophysiological role in ovarian cancer and limits therapeutic efficacy of trametinib.

Autor: Sánchez-Fdez A; Instituto de Biología Molecular y Celular del Cáncer-CSIC, Salamanca, Spain.; Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Salamanca, Spain.; Moores Cancer Center, University of California San Diego, La Jolla, CA, USA., Matilla-Almazán S; Instituto de Biología Molecular y Celular del Cáncer-CSIC, Salamanca, Spain.; Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Salamanca, Spain., Montero JC; Instituto de Biología Molecular y Celular del Cáncer-CSIC, Salamanca, Spain.; Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Salamanca, Spain.; Department of Pathology, University Hospital of Salamanca, Salamanca, Spain., Del Carmen S; Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain.; Department of Pathology, University Hospital of Salamanca, Salamanca, Spain., Abad M; Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain.; Department of Pathology, University Hospital of Salamanca, Salamanca, Spain., García-Alonso S; Instituto de Biología Molecular y Celular del Cáncer-CSIC, Salamanca, Spain.; Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Salamanca, Spain., Bhattacharya S; Cancer Biology and Immunotherapies Group, Sanford Research, Sioux Falls, South Dakota, USA., Calar K; Cancer Biology and Immunotherapies Group, Sanford Research, Sioux Falls, South Dakota, USA., de la Puente P; Cancer Biology and Immunotherapies Group, Sanford Research, Sioux Falls, South Dakota, USA.; Department of Surgery, Sanford School of Medicine, University of South Dakota, Sioux Falls, South Dakota, USA., Ocaña A; Experimental Therapeutics Unit CRIS-Cancer, Hospital Clínico San Carlos and CIBERONC, Madrid, Spain.; Universidad de Castilla La Mancha, Castilla La Mancha, Albacete, Spain., Pandiella A; Instituto de Biología Molecular y Celular del Cáncer-CSIC, Salamanca, Spain.; Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Salamanca, Spain., Esparís-Ogando A; Instituto de Biología Molecular y Celular del Cáncer-CSIC, Salamanca, Spain.; Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Salamanca, Spain.

Publikováno v: Clinical and translational medicine [Clin Transl Med] 2023 Apr; Vol. 13 (4), pp. e1217.

An Analytical Method to Determine Selected Nitro-PAHs in Soil Samples by HPLC With Fluorescence Detection.

Autor: GARCÍA-ALONSO, S.¹ (AUTHOR) susana.garcia@ciemat.es, BARRADO-OLMEDO, A.I.¹ (AUTHOR), PÉREZ-PASTOR, R.M.¹ (AUTHOR)

Publikováno v: Polycyclic Aromatic Compounds. Oct-Dec2012, Vol. 32 Issue 5, p669-682. 14p. 5 Charts, 2 Graphs.

Structure of the RAF1-HSP90-CDC37 complex reveals the basis of RAF1 regulation.

Autor: García-Alonso S; Experimental Oncology Group, Molecular Oncology Programme, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid 28029, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, 28029 Madrid, Spain., Mesa P; Structural Molecular Biology Group, Novo Nordisk Foundation Centre for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen 2200, Denmark., Ovejero LP; Experimental Oncology Group, Molecular Oncology Programme, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid 28029, Spain., Aizpurua G; Experimental Oncology Group, Molecular Oncology Programme, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid 28029, Spain., Lechuga CG; Experimental Oncology Group, Molecular Oncology Programme, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid 28029, Spain., Zarzuela E; Proteomics Unit, Biotechnology Programme, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid 28029, Spain., Santiveri CM; Spectroscopy and NMR Unit, Structural Biology Programme, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid 28029, Spain., Sanclemente M; Experimental Oncology Group, Molecular Oncology Programme, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid 28029, Spain., Muñoz J; Proteomics Unit, Biotechnology Programme, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid 28029, Spain., Musteanu M; Department Section of Biochemistry and Molecular Biology, Complutense University of Madrid, Madrid 28040, Spain., Campos-Olivas R; Spectroscopy and NMR Unit, Structural Biology Programme, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid 28029, Spain., Martínez-Torrecuadrada J; Crystallography and Protein Engineering Unit, Structural Biology Programme, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid 28029, Spain., Barbacid M; Experimental Oncology Group, Molecular Oncology Programme, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid 28029, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, 28029 Madrid, Spain. Electronic address: mbarbacid@cnio.es., Montoya G; Structural Molecular Biology Group, Novo Nordisk Foundation Centre for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen 2200, Denmark. Electronic address: guillermo.montoya@cpr.ku.dk.

Publikováno v: Molecular cell [Mol Cell] 2022 Sep 15; Vol. 82 (18), pp. 3438-3452.e8. Date of Electronic Publication: 2022 Sep 01.